Author

J. Peeters

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Assay:ChIP-seq· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2

Frequent Co-Authors

F. van Wijk· 2 shared J. van Loosdregt· 2 shared M. Mokry· 2 shared R. Scholman· 2 shared S. Vervoort· 2 shared A. Boltjes· 1 shared A. Pandit· 1 shared A. Petrelli· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

F. van Wijk

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Increased EZH2 function in regulatory T cells promotes their capacity to suppress autoimmunity by driving effector differentiation prior to activation

J. Peeters, S. Silveria, M. Ozdemir, S. Ramachandran, M. DuPage

This study shows that increased EZH2 activity in regulatory T cells enhances their effector differentiation and autoimmunity suppression capacity.

bioRxiv · Apr 5, 2024 · PreprintImmunology

Epigenetic changes in autoimmune monocytes contribute to disease and can be targeted by JAKinhibition

J. van Loosdregt, J. Peeters, A. Boltjes, R. Scholman, S. Vervoort, P. Coffer, M. Mokry, B. Vastert, F. van Wijk

The paper investigates epigenetic changes in monocytes from JIA patients and shows JAK inhibition can reverse disease-related gene expression.

bioRxiv · Nov 20, 2021 · PreprintImmunology

Conserved human effector Treg signature is reflected in transcriptomic and epigenetic landscape

G. Mijnheer, L. Lutter, M. Mokry, M. van der Wal, V. Fleskens, R. Scholman, A. Pandit, W. Tao, M. Wekking, S. Vervoort, C. Roberts, A. Petrelli, J. Peeters, M. Knijff, S. de Roock, , F. van Wijk

The paper identifies a conserved human effector Treg signature through transcriptomic and epigenetic analysis, showing overlap with tumor-infiltrating Treg and environment-driven adaptations.

bioRxiv · Sep 30, 2020 · PreprintImmunology